|
Tor Tosteson for SPORT
DMS magazine article
Linda Titus-Ernstoff for Smoking in movies
DMS magazine article
Reuters article
Selenium may prevent high risk-bladder cancer - American Association for Cancer Research December, 2008 A study published in the December issue of Cancer Prevention Research suggests that selenium, a trace mineral found in grains, nuts and meats, may aid in the prevention of high-risk bladder cancer.
Researchers from Dartmouth Medical School compared selenium levels in 767 individuals newly diagnosed with bladder cancer to the levels of 1,108 individuals from the general population. Findings showed an inverse association between selenium and bladder cancer among women, some smokers and those with p53 positive bladder cancer.
Read more: Superfund Research Brief, MedPageToday.com (12/11/08), e! Science News (12/8/08)
Dartmouth's Toxic Metals Research Group awarded $14.5 million grant renewal - Dartmouth
News Fall 2008
Dartmouth College and Dartmouth Medical School scientists have been awarded a renewal grant of $14.5 million dollars from the National Institute of Environmental Health Sciences (NIEHS) through the Superfund Basic Research Program to understand the human health impact of exposure to arsenic and mercury. Not only does this renewal grant, which will carry through to 2013, support one of the longest running, continually funded interdisciplinary science projects at Dartmouth, it also represents one of the longest continually funded programs in the history of the NIEHS Superfund Basic Research Program. Since its inception in 1995, the Dartmouth Toxic Metals Research Group has been awarded $42.8 million from the NIEHS.
Read more
Dartmouth Researcher Confirms Vioxx Cardiovascular Risk - Dartmouth
Medicine Magazine Fall 2008
Long term follow-up confirms that use of the former pain killer rofecoxib (Vioxx) substantially increased the risk of cardiovascular events such as stroke and heart attack. The results were published early online and in an upcoming edition of the Lancet by Dr. John A Baron, professor of medicine and of community and family medicine. They highlight the need to balance potential and perils when considering such drugs, called COX-2 inhibitors, which are non-steroidal anti-inflammatory drugs (NSAIDs).
Read more
|
